InsidersTradesSigma
Track the CLEARPOINT NEURO INC stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). The latest transaction was disclosed on 29 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: JOSEPH BURNETT. The full history is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
CLEARPOINT NEURO INC is a company focused on developing surgical navigation technologies for the treatment of neurological disorders. It aims to improve clinical outcomes through innovative solutions.